CANTEL MEDICAL CORP. (NYSE:CMD) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security
Holders.
At the 2016 Annual Meeting, held on January5, 2017, three
proposals were voted on by the Companys stockholders.The
proposals are described in detail in the Companys definitive
proxy statement filed on November28, 2016 (the Proxy Statement)
in connection with the 2016 Annual Meeting and summarized below.
A final voting report was produced by Broadridge Financial
Solutions,Inc., the independent inspector of election for the
2016 Annual Meeting, certifying the following results on the
three proposals:
Proposal 1 The stockholders elected all nine director nominees to
serve as members of the Companys board of directors until the
Companys 2017 Annual Meeting of Stockholders.
|
Name |
|
For |
|
Withheld |
|
Abstain |
|
Broker Non-Votes |
|
Alan R. Batkin |
36,079,638 |
718,533 |
17,371 |
2,609,004 |
||||
|
Ann E. Berman |
36,559,252 |
239,236 |
17,054 |
2,609,004 |
||||
|
Charles M. Diker |
35,380,416 |
1,416,432 |
18,694 |
2,609,004 |
||||
|
Mark N. Diker |
35,535,474 |
1,262,331 |
17,737 |
2,609,004 |
||||
|
Anthony B. Evnin |
36,446,941 |
343,714 |
24,887 |
2,609,004 |
||||
|
Laura L. Forese |
36,556,963 |
241,138 |
17,441 |
2,609,004 |
||||
|
George L. Fotiades |
36,539,534 |
250,734 |
25,274 |
2,609,004 |
||||
|
Jorgen B. Hansen |
36,187,104 |
610,997 |
17,441 |
2,609,004 |
||||
|
Ronnie Myers |
36,563,596 |
234,505 |
17,441 |
2,609,004 |
Proposal 2 The stockholders approved, on an advisory basis, the
compensation of the Companys Named Executive Officers.
|
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
|
35,638,918 |
1,149,828 |
26,796 |
2,609,004 |
Proposal 3 The stockholders ratified the appointment of Ernst
Young LLP as the Companys Independent Registered Public
Accounting Firm for the fiscal year ending July31, 2017.
|
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
|
38,745,700 |
668,327 |
10,519 |
|
About CANTEL MEDICAL CORP. (NYSE:CMD)
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The Company’s Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The Company’s Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The Company offers a range of filters utilizing hollow fiber membrane technology. CANTEL MEDICAL CORP. (NYSE:CMD) Recent Trading Information
CANTEL MEDICAL CORP. (NYSE:CMD) closed its last trading session down -0.85 at 78.33 with 186,060 shares trading hands.